Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008-2018: The EACH-WOMAN Project.
Hughes KC, Herring TA, Song JN, Gately RV, Przybyl LM, Ogilvie RP, Simon K, Bhuyan PK, Kyrgiou M, Seeger JD.
Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.
Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N.
Wnt3a/beta-Catenin/CBP Activation in the Progression of Cervical Intraepithelial Neoplasia.
Feng D, Lin J, Wang W, Yan K, Liang H, Liang J, Yu H, Ling B.
Pathol Oncol Res. 2021 Mar 31;27:609620. doi: 10.3389/pore.2021.609620. eCollection 2021.
PMID:34257574
Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.
Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, Bhatia R, Lyons D, Paraskevaidis E, Li JV, Holmes E, Nicholson JK, Bennett PR, Kyrgiou M.
Sci Rep. 2015 Nov 17;5:16865. doi: 10.1038/srep16865.
PMID:26574055
Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
Wang J, Li M, Zhao L, Zhou B, Chen H, Duan F, Wang G.
Medicine (Baltimore). 2023 Nov 10;102(45):e35953. doi: 10.1097/MD.0000000000035953.